Back

Omega-3-fatty-acid eicosapentaenoic acid (EPA) associates with reduced QTc in patients with atrial fibrillation

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lifestyle modification: atrial fibrillation and risk stratification Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Meret Sarah Allemann

University of Zurich, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Real-world implantable cardioverter-defibrillator outcomes in a north-african tertiary centre: baseline profile, arrhythmic therapies, device-related events and early outcomes
Doctor N. Dahimene (Tipaza, DZ)
Abstract Slides
Presentation thumbnail
Development of a risk stratification model for permanent pacemaker implantation after Transcatheter Aortic Valve Replacement (TAVR)
Professor T. Liu (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Optimal near-field unipolar voltage thresholds using a lattice-tip mapping catheter corresponding to bipolar low-voltage areas in atrial fibrillation ablation
Doctor T. Ozaki (Osaka, JP)
Abstract Slides
Presentation thumbnail
Lifestyle profile and adverse outcomes in atrial fibrillation: a modified life’s simple 7 (LS7) analysis from two prospective observational registries from europe and east Asia
Doctor E. Tartaglia (Modena, IT)
Abstract Slides
Presentation thumbnail
Changes in cardiorespiratory fitness in non-permanent atrial fibrillation and quality of life
Mr A. Sellevold (Trondheim, NO)
Abstract Slides

Access the full session

Session thumbnail
Lifestyle modification: atrial fibrillation and risk stratification

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
thumbnail
Congress Presentation
Accuracy of QTc measurement using a smartwatch mECG in long QT syndrome
1 September 2025
thumbnail
Congress Presentation
Epicardial adipose tissue and its association with atrial fibrillation in middle-aged patients without overt heart disease
10 May 2023
thumbnail
Congress Presentation
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources